Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 887
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +12.2%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 401–427 of 427 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06588179	SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt	not yet recruiting	Phase 1 / Phase 2	58	Fudan UniversityOTHER	1	Sep 19, 2024	clinicaltrials
NCT06577961	Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients	not yet recruiting	Phase 1 / Phase 2	37	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	0	Aug 29, 2024